COMMUNIQUÉS West-GlobeNewswire

Vireo Growth Inc. to Release Second Quarter 2024 Results on August 6, 2024

23/07/2024 - 14:01

MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (formerly Goodness Growth Holdings, Inc.) ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), a cannabis company committed to providing safe access, [...]

BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024

23/07/2024 - 14:00

BURLINGTON, Mass. and JERUSALEM, July 23, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental [...]

Spectral AI Adds Three New Clinical Trial Sites To Expedite Emergency Department Patient Enrollment

23/07/2024 - 14:00

DALLAS, July 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]

Spinogenix Announces Enrollment is Open for its Phase 2 Clinical Trial of SPG601 in Fragile X Syndrome

23/07/2024 - 14:00

U.S. FDA has granted Orphan Drug Designation to SPG601 for the Treatment of Fragile X Syndrome SPG601 is a novel small molecule that works by correcting specific synaptic dysfunctions in the brain to address core [...]

Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in France

23/07/2024 - 14:00

MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]

Inspire Medical Systems, Inc. annonce le remboursement de son dispositif en France

23/07/2024 - 14:00

MINNEAPOLIS, 23 juill. 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE : INSP) (Inspire), entreprise spécialisée dans les technologies médicales axée sur le développement et la commercialisation de [...]

Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

22/07/2024 - 22:45

SARASOTA, FL, July 22, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery [...]

Cronos Group Inc. Announces Results of Reconvened 2024 Annual Meeting of Shareholders

22/07/2024 - 22:15

TORONTO, July 22, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders (the “Meeting”) reconvened July 19, 2024, [...]

Cytel Unveiled as OneMedNet’s Newest Alliance Partner

22/07/2024 - 22:15

Cytel’s software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies MINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) -- Further to its press release [...]

TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

22/07/2024 - 22:07

BOSTON, July 22, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to more effectively treating cancer using RNA [...]

Sanofi: Information concerning the total number of voting rights and shares – June 2024

22/07/2024 - 22:05

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]

Sanofi: Informations relatives au nombre de droits de vote et d'actions – Juin 2024

22/07/2024 - 22:05

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]

TELA Bio to Announce Second Quarter 2024 Financial Results

22/07/2024 - 22:05

MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]

Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024

22/07/2024 - 22:05

ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial [...]

Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

22/07/2024 - 22:05

MENLO PARK, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on July 29, 2024. The [...]

RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024

22/07/2024 - 22:05

ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]

T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024

22/07/2024 - 22:05

LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report [...]

OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th

22/07/2024 - 22:05

BETHLEHEM, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2024 financial results and certain business [...]

OrthoPediatrics Corp. to Report Second Quarter 2024 Financial Results on August 6, 2024

22/07/2024 - 22:05

WARSAW, Ind., July 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]